Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Shares Outstanding (Weighted Average) (2016 - 2025)

Neuroone Medical Technologies' Shares Outstanding (Weighted Average) history spans 14 years, with the latest figure at $50.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 63.21% year-over-year to $50.3 million; the TTM value through Dec 2025 reached $50.3 million, up 63.21%, while the annual FY2025 figure was $100000.0, 99.63% down from the prior year.
  • Shares Outstanding (Weighted Average) reached $50.3 million in Q4 2025 per NMTC's latest filing, up from $100000.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $50.3 million in Q4 2025 to a low of $100000.0 in Q3 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $17.1 million, with a median of $16.1 million recorded in 2022.
  • The largest YoY upside for Shares Outstanding (Weighted Average) was 1913.11% in 2025 against a maximum downside of 99.63% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $15.4 million in 2021, then rose by 5.34% to $16.2 million in 2022, then surged by 47.84% to $24.0 million in 2023, then rose by 28.51% to $30.8 million in 2024, then skyrocketed by 63.21% to $50.3 million in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Shares Outstanding (Weighted Average) are $50.3 million (Q4 2025), $100000.0 (Q3 2025), and $7.0 million (Q2 2025).